Skip to main content
main-content

23-10-2018 | Ovarian cancer | ESMO 2018 | Video

SOLO1 trial of maintenance olaparib in advanced ovarian cancer

SOLO1 co-author Susana Banerjee provides a quick take on the study findings and discusses the challenges going forward (3:55).

More on this topic

image credits